JPRN-jRCTs051190057已完成1 期
Evaluation study of safety of cancer specific PET probe F18-NKO-035 for healthy male adults - NKO-PET study
Watabe Tadashi0 个研究点目标入组 4 人开始时间: 2019年10月8日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 4
研究概览
简要总结
The safety of the F18-NKO-035 injection, a novel probe for the amino acid transporter L- type amino-acid transporter-1 (LAT1) expressed specifically in cancer cells, was evaluated comprehensively.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 < 40age old（—）
- 性别
- Male
入选标准
- •1) An adult male between 20 and 40 years of age
- •2) Person who is judged appropriate as a healthy person by a research principal doctor etc. after blood test, urine test and electrocardiogram test
- •3) Person who have obtained written consent for participation in this study from the applicant
排除标准
- •1) Person with past medical history less than 1
- •Malignant tumor, endocrine disease, heart failure, severe respiratory disease, liver dysfunction, renal dysfunction
- •2) Persons who have a history of severe hypersensitivity to components of PET drugs used in this study
- •3) Persons who have undergone computed tomography (CT), PET or cardiac catheterization within the past year
- •4) Persons who were judged inappropriate by the investigator as a subject
研究者
相似试验
已完成
2 期
sefulness evaluation of PET probe F18-NKO-035JPRN-jRCTs051200075Watabe Tadashi9
招募中
2 期
FET PET in Differentiating Tumour Progression From Pseudoprogression in High Grade GliomaGlioma, MalignantNCT06172595Singapore General Hospital22
已完成
2 期
Reproducibility of Intratumor Distribution of 18F-EF5 in Head and Neck CancerSquamous Cell Carcinoma of the Head and NeckNCT01774760Turku University Hospital10
已完成
1 期
Study of Kinetics, Dosimetry & Safety of [18F]F-AraG, a Positron Emission Tomography Imaging Tracer in Healthy HumansCancerNCT02323893CellSight Technologies, Inc.6
已完成
不适用
Combined F-18 NaF and F-18 FDG PET/CT for Evaluation of MalignancyNeoplasmsNCT00725387Stanford University214